ALAD anticorps
Aperçu rapide pour ALAD anticorps (ABIN2462445)
Antigène
Voir toutes ALAD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Antibody is purified by peptide affinity chromatography method.
-
Immunogène
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human ALAD.
-
-
-
-
Indications d'application
- ALAD antibody can be used for detection of ALAD by ELISA at 1:312500. ALAD antibody can be used for detection of ALAD by western blot at 0.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Conseil sur la manipulation
- As with any antibody avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store ALAD antibody at -20 °C.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Autre désignation
- ALAD
-
Sujet
- The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 Molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria.The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 Molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternatively spliced transcript variants encoding different isoforms have been identified.
-
Poids moléculaire
- 39 kDa, 37 kDa
-
ID gène
- 210
-
NCBI Accession
- NP_001003945
-
UniProt
- Q6ZMU0
Antigène
-